Abstract: A system and method for sharing resources among application modules includes receiving, on an application including a plurality of modules, a resource from a server; determining a storage position identifier corresponding to an identifier of the resource and indicative of a storage position in a database for storing resources dedicated for the application; and storing the resource in the database based on the determined identifier for sharing among the plurality of modules.

Abstract: There are provided methods and devices for programming a luminaire. For example, there is provided a programming module for use with a luminaire. The programming module includes a connector configured to provide an interface between the programming module and the luminaire via a photo-electric element (PE) socket of the luminaire. The programming module further includes a memory and a processor. When executing instructions included in the memory, the processor is configured to perform operations that include measuring the input power to the luminaire and changing a driver current set point.

Abstract: Provided is a hydrostatic transmission including a pump/motor module having a reservoir housing and a hydraulic pump and motor disposed in the reservoir housing, and a speed reduction module having a speed reduction housing coupled to the reservoir housing and a speed reduction assembly disposed in the speed reduction housing. The speed reduction assembly includes an input member driven by the output shaft of the hydraulic motor, an output member rotationally connected to the input member by one or more belts/chains, and an axle shaft driven by rotation of the output member. By providing the speed reduction assembly in a separate housing from the hydraulic fluid in the reservoir housing, the speed reduction assembly is isolated from the hydraulic fluid thereby preventing particulates from the speed reduction assembly from entering the hydraulic fluid in the reservoir housing.

Abstract: There is provided a landing platform for mounting on a luminaire, where the landing platform provides an interface to a drone. For example, there is provided a landing platform for a drone, the landing platform being adaptable to mount on a luminaire. The landing platform includes two electrically active portions and an elevated portion. The elevated portion is configured to secure the drone on the landing platform and provide electrical contact between the two electrically active portions and electrical connectors of the drone.

Abstract: An indirect evaporative cooling system with a core greatly reduced in size compared to conventional evaporative cooling systems The system has a heat exchanger core having heat exchange plates defining a plurality of wet air flow passages and a plurality of dry air flow passages. At least one fan drives air through the passages. The dry air passages have a small height and a short length, configured so that a substantially laminar airflow having a raised shear rate arises in the dry air passages, and so that a back pressure across a length of the dry air passages remains low.

Abstract: Azaindazole compounds for treating various diseases and pathologies are disclosed. More particularly, the present invention concerns the use of an azaindazole compound or analogs thereof, in the treatment of disorders characterized by the activation of Wnt pathway signaling (e.g., cancer, abnormal cellular proliferation, angiogenesis, fibrotic disorders, bone or cartilage diseases, and osteoarthritis), the modulation of cellular events mediated by Wnt pathway signaling, as well as genetic diseases and neurological conditions/disorders/diseases due to mutations or dysregulation of the Wnt pathway and/or of one or more of Wnt signaling components. Also provided are methods for treating Wnt-related disease states.

Abstract: Indazole compounds for treating various diseases and pathologies are disclosed. More particularly, the present invention concerns the use of an indazole compound or analogs thereof, in the treatment of disorders characterized by the activation of Wnt pathway signaling (e.g., cancer, abnormal cellular proliferation, angiogenesis, Alzheimer's disease and osteoarthritis), the modulation of cellular events mediated by Wnt pathway signaling, as well as genetic diseases due to mutations in Wnt signaling components. Also provided are methods for treating Wnt-related disease states.

Abstract: Azaindazole compounds for treating various diseases and pathologies are disclosed. More particularly, the present invention concerns the use of an azaindazole compound or analogs thereof, in the treatment of disorders characterized by the activation of Wnt pathway signaling (e.g., cancer, abnormal cellular proliferation, angiogenesis, fibrotic disorders, bone or cartilage diseases, and osteoarthritis), the modulation of cellular events mediated by Wnt pathway signaling, as well as genetic diseases and neurological conditions/disorders/diseases due to mutations or dysregulation of the Wnt pathway and/or of one or more of Wnt signaling components. Also provided are methods for treating Wnt-related disease states.

Abstract: The present invention is a photochromic eyewear lens product comprising photochromics material(s) and selective filtering agent(s) that selectively attenuate a portion of the blue light spectral region between 400 nm and 500 nm. The selective attenuation preferably comprises a maximum reduction in transmittance in the filtered region of about 10-25% T relative to at least one adjacent spectral region when the lens product is in the rest state, and a maximum reduction in transmittance that is measurably less than the transmittance of at least one adjacent region of the visible spectrum when the lens product has darkened in the activated state.

Abstract: Azaindazole compounds for treating various diseases and pathologies are disclosed. More particularly, the present invention concerns the use of an azaindazole compound or analogs thereof, in the treatment of disorders characterized by the activation of Wnt pathway signaling (e.g., cancer, abnormal cellular proliferation, angiogenesis, fibrotic disorders, bone or cartilage diseases, and osteoarthritis), the modulation of cellular events mediated by Wnt pathway signaling, as well as genetic diseases and neurological conditions/disorders/diseases due to mutations or dysregulation of the Wnt pathway and/or of one or more of Wnt signaling components. Also provided are methods for treating Wnt-related disease states.

Abstract: Indazole compounds for treating various diseases and pathologies are disclosed. More particularly, the present invention concerns the use of an indazole compound or analogs thereof, in the treatment of disorders characterized by the activation of Wnt pathway signaling (e.g., cancer, abnormal cellular proliferation, angiogenesis, fibrotic disorders, bone or cartilage diseases, and osteoarthritis), the modulation of cellular events mediated by Wnt pathway signaling, as well as genetic diseases and neurological conditions/disorders/diseases due to mutations or dysregulation of the Wnt pathway and/or of one or more of Wnt signaling components. Also provided are methods for treating Wnt-related disease states.

Abstract: The present disclosure provides ?-diketones or analogs thereof, that activate Wnt/?-catenin signaling and thus treat or prevent diseases related to signal transduction, such as osteoporosis and osteoarthropathy; osteogenesis imperfecta, bone defects, bone fractures, periodontal disease, otosclerosis, wound healing, craniofacial defects, oncolytic bone disease, traumatic brain injuries or spine injuries, brain atrophy/neurological disorders related to the differentiation and development of the central nervous system, including Parkinson's disease, strokes, ischemic cerebral disease, epilepsy, Alzheimer's disease, depression, bipolar disorder, schizophrenia; otic disorders like cochlear hair cell loss; eye diseases such as age related macular degeneration, diabetic macular edema or retinitis pigmentosa and diseases related to differentiation and growth of stem cell, such as hair loss, hematopoiesis related diseases and tissue regeneration related diseases.

Abstract: Azaindazole compounds for treating various diseases and pathologies are disclosed. More particularly, the present invention concerns the use of an azaindazole compound or analogs thereof, in the treatment of disorders characterized by the activation of Wnt pathway signaling (e.g., cancer, abnormal cellular proliferation, angiogenesis, fibrotic disorders, bone or cartilage diseases, and osteoarthritis), the modulation of cellular events mediated by Wnt pathway signaling, as well as genetic diseases and neurological conditions/disorders/diseases due to mutations or dysregulation of the Wnt pathway and/or of one or more of Wnt signaling components. Also provided are methods for treating Wnt-related disease states.

Abstract: The present application discloses a compound which is which activates Wnt/?-catenin signaling and thus treats or prevents diseases related to signal transduction, such as osteoporosis and osteoarthropathy; osteogenesis imperfecta, bone defects, bone fractures, periodontal disease, otosclerosis, wound healing, craniofacial defects, oncolytic bone disease, traumatic brain injuries related to the differentiation and development of the central nervous system, comprising Parkinson's disease, strokes, ischemic cerebral disease, epilepsy, Alzheimer's disease, depression, bipolar disorder, schizophrenia; eye diseases such as age related macular degeneration, diabetic macular edema or retinitis pigmentosa and diseases related to differentiation and growth of stem cell, comprising hair loss, hematopoiesis related diseases and tissue regeneration related diseases.

Abstract: Indazole compounds for treating various diseases and pathologies are disclosed. More particularly, the present disclosure concerns the use of an indazole compound or analogs thereof, in the treatment of disorders characterized by the activation of Wnt pathway signaling (e.g., cancer, abnormal cellular proliferation, angiogenesis, Alzheimer's disease, lung disease, fibrotic disorders, cartilage (chondral) defects, and osteoarthritis), the modulation of cellular events mediated by Wnt pathway signaling, and neurological conditions/disorders/diseases linked to overexpression of DYRK1A.

Abstract: Indazole compounds for treating various diseases and pathologies are disclosed. More particularly, the present invention concerns the use of an indazole compound or analogs thereof, in the treatment of disorders characterized by the activation of Wnt pathway signaling (e.g., cancer, abnormal cellular proliferation, angiogenesis, fibrotic disorders, bone or cartilage diseases, and osteoarthritis), the modulation of cellular events mediated by Wnt pathway signaling, as well as genetic diseases and neurological conditions/disorders/diseases due to mutations or dysregulation of the Wnt pathway and/or of one or more of Wnt signaling components. Also provided are methods for treating Wnt-related disease states.

Abstract: The present invention describes composite constructed ophthalmic lenses comprising at least two layers of optical materials that provide a composite structure over a practical vision zone of the lens product, are identifiably disparate from each other, and are integrally bonded to each other such that the adhesion of the first layer to the second layer exceeds a ranking of at least 3 when tested according to specified tests. In a preferred embodiment, one layer comprises thermoplastic polycarbonate and the second layer comprises polyurea-urethane material and one or more additives. The first layer may comprise a polarizer. The composite lens may also comprise coatings or other components.

Abstract: Azaindazole compounds for treating various diseases and pathologies are disclosed. More particularly, the present invention concerns the use of an azaindazole compound or analogs thereof, in the treatment of disorders characterized by the activation of Wnt pathway signaling (e.g., cancer, abnormal cellular proliferation, angiogenesis, fibrotic disorders, bone or cartilage diseases, and osteoarthritis), the modulation of cellular events mediated by Wnt pathway signaling, as well as genetic diseases and neurological conditions/disorders/diseases due to mutations or dysregulation of the Wnt pathway and/or of one or more of Wnt signaling components. Also provided are methods for treating Wnt-related disease states.

Abstract: A convection fan includes a plurality of blades mounted for rotation with a shaft, a guiding plate mounted to partially surround the plurality of blades, and a fan-motor mount. The fan-motor mount includes a top plate and a bottom plate through which the shaft extends, a motor fastener that mounts a motor to the bottom plate in isolation from the top plate, a guiding plate fastener that mounts the guiding plate to the top plate in isolation from the bottom plate, an insulator between the top plate and the bottom plate, and a plate fastener that mounts the top plate to the bottom plate. The plate fastener includes a fastener and a standoff that surrounds a portion of the fastener between the top plate and the bottom plate and within the bottom plate to provide a thermal break.